Kenya - inglise - Pharmacy and Poisons Board

ibsa institut biochimique sa via al ponte 13, 6903 lugano (switzerland) - follicular stimulating hormone(fsh), lutenizing… - powder and solvent for solution for injection - 75 iu - gonadotropins

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

standard homeopathic company - lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479) - belching or bloating

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

standard homeopathic company - lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479) - belching or bloating

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

quality care products, llc - diclofenac epolamine (unii: x5f8ekl9zg) (diclofenac - unii:144o8ql0l1) - diclofenac epolamine 180 mg in 14 g - flector® patch is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions. flector patch is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1) ] - flector patch is contraindicated for use on non-intact or damaged skin resulting from any etiology, including exudative dermatitis, eczema, infection lesions, burns or wounds. risk summary published literature reports that use of nsaids, including flector patch, after 30 weeks' gestation increases the risk of premature closu

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

preferred pharmaceucitalc inc. - diclofenac epolamine (unii: x5f8ekl9zg) (diclofenac - unii:144o8ql0l1) - diclofenac epolamine 180 mg - flector® patch is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions. flector patch is contraindicated in the following patients: risk summary published literature reports that use of nsaids, including flector patch, after 30 weeks' gestation increases the risk of premature closure of the fetal ductus arteriosus. data from observational studies regarding potential embryofetal risks of nsaid use, including diclofenac, in women in the first or second trimester of pregnancy are inconclusive. avoid use of nsaids, including flector patch, in pregnant women starting at 30 weeks of gestation (third trimester) (see clinical considerations and data) . in animal reproduction studies, diclofenac epolamine administered orally to pregnant rats and rabbits during the period of organogenesis produced embryotoxicity at approximately 3 and 7 times, respectively, the topical exposure from the maximum recommended human dose (mrhd) of flector patch. in rats, increased incidences of

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (united states) - levothyroxine sodium anhydrous - oral capsule - 50microgram

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

certis belchim nv - pyridate - unknown - pyridate pyridazine active 0.0 - active constituent

Iisrael - inglise - Ministry of Health

genmedix , israel - calcitonin salmon; calcitonin salmon - solution for injection - calcitonin salmon 100 iu/ml; calcitonin salmon 100 iu/ml - calcitonin (salmon synthetic) - calcitonin (salmon synthetic) - calcitonin is indicated for:• prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures.• for the treatment of paget's disease, only in patients who do not respond to alternative treatments or for whom such treatments are not suitable, for example those with severe renal impairment.• treatment of hypercalcemia of malignancy. calcitonin is indicated for:• prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures.• for the treatment of paget's disease, only in patients who do not respond to alternative treatments or for whom such treatments are not suitable, for example those with severe renal impairment.• treatment of hypercalcemia of malignancy.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

h.j. harkins company, inc. - diclofenac epolamine (unii: x5f8ekl9zg) (diclofenac - unii:144o8ql0l1) - diclofenac epolamine 180 mg - - flector patch is contraindicated in patients with a known hypersensitivity to diclofenac. - flector patch is contraindicated in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.13)]. - flector patch is contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1)]. - flector patch is contraindicated for use on non-intact or damaged skin resulting from any etiology, including exudative dermatitis, eczema, infection lesions, burns or wounds. teratogenic effects pregnancy category c prior to 30 weeks gestation; category d starting 30 weeks gestation. starting at 30 weeks gestation, avoid use of flector patch, and other nsaids, in pregnant women as premature closure of the ductus arteriosus in the fetus may occur, flector pat

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

certis belchim nv - pyridate - unknown - pyridate pyridazine active 0.0 - active constituent